SIC47-94

Villa, M., Malighetti, F., Sharma, G., Arosio, G., Sala, E., Manfroni, C., et al. (2022). Novel ALK mutations in EML4::ALK+ NSCLC resistant to TKIs identified by liquid biopsy. Intervento presentato a: 62nd SIC Annual Meeting. The exciting path from preclinical research to clinical application, Venezia, Italia.

Novel ALK mutations in EML4::ALK+ NSCLC resistant to TKIs identified by liquid biopsy

Villa, M;Malighetti, F;Arosio, G;Manfroni, C;Fontana, D;Cordani, N;Meneveri, R;Zambon, A;Piazza, R;Pagni, F;Cortinovis, D;Mologni, L
2022

Abstract

SIC47-94
abstract + poster
ctDNA, ALK+NSCLC
English
62nd SIC Annual Meeting. The exciting path from preclinical research to clinical application
2022
2022
none
Villa, M., Malighetti, F., Sharma, G., Arosio, G., Sala, E., Manfroni, C., et al. (2022). Novel ALK mutations in EML4::ALK+ NSCLC resistant to TKIs identified by liquid biopsy. Intervento presentato a: 62nd SIC Annual Meeting. The exciting path from preclinical research to clinical application, Venezia, Italia.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/408276
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
Social impact